Company intelligence / Profile preview

Synergist Medical

Baltimore, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Synergist Medical is a medical technology company focused on developing advanced diagnostic tools for neuro-ophthalmic conditions. The company's primary innovation is a portable, automated pupillometer designed to objectively measure the Relative Afferent Pupillary Defect (RAPD). By replacing subjective manual exams with precise digital measurements, the device aims to improve the detection and monitoring of conditions such as glaucoma, optic neuritis, and traumatic brain injury. Synergist Medical's technology leverages proprietary algorithms to provide clinicians with actionable data in various clinical settings.

Therapeutic areas: NeurologyOphthalmology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Johns Hopkins University

Beyond the preview

Go deeper on Synergist Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synergist Medical.

Explore the full profile